-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OMO-2 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMO-2 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OMO-2 in Non-Small Cell Lung Cancer Drug Details: OMO-2 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4532990 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4532990 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: ARO-HSD is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rapirosiran Sodium in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rapirosiran Sodium in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rapirosiran Sodium in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4532990 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4532990 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4532990 in Non-Alcoholic Steatohepatitis (NASH) Drug Details: ARO-HSD is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OG-6219 in Endometriosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OG-6219 in Endometriosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OG-6219 in Endometriosis Drug Details: FP-6219 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rapirosiran Sodium in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rapirosiran Sodium in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Rapirosiran Sodium in Non-Alcoholic Steatohepatitis (NASH)Drug Details:Rapirosiran (ALN-HSD) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ADPT-03 in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ADPT-03 in Sickle Cell Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ADPT-03 in Sickle Cell DiseaseDrug Details:ADPT-03 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XTX-101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XTX-101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XTX-101 in Solid Tumor Drug Details: XTX-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elraglusib in Angiosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elraglusib in Angiosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elraglusib in Angiosarcoma Drug Details: 9-ING41 is under development for the treatment of...
-
Product Insights
HST/HSD Project Field, Vietnam
HST/HSD Project Field is a producing field located in South China Sea, Vietnam. It is being operated by Thanglong Joc. Empower your strategies with our HST/HSD Project Field, Vietnam report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...